Neorx Corporation
Records under this name other than patents Neorx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,515,009 | Therapeutic inhibitor of vascular smooth muscle cells Formerly held Term ended Ended no later than Feb 4, 2020 · USPTO record | Term ended | Ended no later than Feb 4, 2020 | USPTO record |
| US 6,117,551 | Carbon fiber prepreg, and a production process thereof Formerly held Term ended Term ended Aug 11, 2018 · USPTO record | Term ended | Term ended Aug 11, 2018 | USPTO record |
| US 6,251,920 | Prevention and treatment of cardiovascular pathologies Formerly held Term ended Term ended May 21, 2018 · USPTO record | Term ended | Term ended May 21, 2018 | USPTO record |
| US 6,989,435 | Compounds and methods to inhibit or augment an inflammatory response Formerly held Lapsed on the fee record Ended Jan 24, 2018 · USPTO record | Lapsed on the fee record | Ended Jan 24, 2018 | USPTO record |
| US 6,197,789 | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues Formerly held Term ended Term ended Dec 5, 2017 · USPTO record | Term ended | Term ended Dec 5, 2017 | USPTO record |
| US 6,166,090 | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells Formerly held Term ended Term ended Nov 6, 2017 · USPTO record | Term ended | Term ended Nov 6, 2017 | USPTO record |
| US 7,605,239 | Skeletal-targeted radiation to treat bone-associated pathologies Formerly held Lapsed on the fee record Ended Oct 20, 2017 · USPTO record | Lapsed on the fee record | Ended Oct 20, 2017 | USPTO record |
| US 8,481,558 | Compounds to Inhibit or Augment an Inflammatory Response Lapsed on the fee record Ended Jul 9, 2017 · Medium confidence | Lapsed on the fee record | Ended Jul 9, 2017 | Medium confidence |
| US 7,511,070 | Compounds and therapies for the prevention of vascular and non-vascular pathologies Formerly held Lapsed on the fee record Ended Mar 31, 2017 · USPTO record | Lapsed on the fee record | Ended Mar 31, 2017 | USPTO record |
| US 6,024,937 | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging Formerly held Term ended Term ended Feb 15, 2017 · USPTO record | Term ended | Term ended Feb 15, 2017 | USPTO record |